CME Group Inc. (CME)

NASDAQ: CME · USD

$255

+0.05 (+0.0%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-07-28 02:00 UTC. Latest published research analyzed 2026-05-20 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh CME analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-20

Our latest published analysis: CME rated Reduce

CME is rated Reduce at $302.37 versus the reconciled fair value midpoint of $261.16, implying -13.63% upside/downside. Confidence is separately disclosed at 88/100.

Fair value (mid)

$261 / share

$181 – $341

Upside to FV

-13.6%

from $255

Confidence

88/100

Moat

9/10

Read full analysis

Market cap	$109.6B
Revenue (ttm)	6.8B
Net income (ttm)	4.3B
EPS (ttm)	$11.8
Shares out	359.6M
P/E (trailing)	21.7x
P/E (forward)	23.5x
Dividend	$11.4 (4.45%)
Volume	1,675,522
Beta	0.28
Price target	$284	+11.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.8B
Net income (ttm): 4.3B
EPS (ttm): $11.8
P/E (trailing): 21.7x
P/E (forward): 23.5x
Market cap: $109.6B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$4.69B	$5.02B	$5.58B	$6.13B	$6.52B	+8.6%
Gross profit	$3.85B	$4.27B	$4.75B	$5.28B	$5.61B	+9.9%
Operating income	$2.65B	$3.02B	$3.44B	$3.93B	$4.23B	+12.4%
Net income	$2.64B	$2.69B	$3.23B	$3.53B	$4.07B	+11.5%
EPS (diluted)	$7.29	$7.40	$8.86	$9.67	$11.16	+11.2%
EBITDA	$3.93B	$4.02B	$4.67B	$5.04B	$5.83B	+10.4%
R&D	—	—	—	—	—	—
SG&A	$151.7M	$137.4M	$144.4M	$132.7M	$150.5M	-0.2%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	40.8x	11.1x	104.3%	+6.8%	+59.6%	Sell
ABNB	Airbnb Inc.	90.9B	37.5x	7.2x	15.9%	+29.9%	+8.3%	Hold
ADBE	Adobe Inc.	99B	14.3x	3.9x	60.7%	+11.9%	-32.8%	Strong Buy
AXP	American Express Company	227.3B	20.4x	3.2x	11.9%	+13.2%	+9.2%	Reduce
BAC	Bank of America Corporation	439.5B	14.5x	3.9x	—	+5.6%	+32.1%	Reduce
BK	The Bank of New York Mellon Corporation	—	—	—	—	—	—	Reduce

All CME indicators

Market & fundamental data

Available fields

293

Groups with data

Currency

USD

Showing 293 of 293 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001156375
Company name	CME Group Inc.
Country	United States
Country code	US
Cusip	12572Q105
Employees	3,875
Employees Change	115%
Employees Change Percent	3.06
Enterprise value	$93.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Financial Data & Stock Exchanges
Industry PE	25.3
Industry PE Fwd	22.41
IPO Date	2002-12-06
Isin	US12572Q1058
Last refreshed	2026-07-28
Market cap	$91.8B
Market cap category	Large-Cap
Price	$255
Price currency	USD
Rev Per Employee	1,743,793.55x
Sector	Financials
Sector PE	17.08
Sector PE Fwd	14.39
Sic	6200
Symbol	CME
Website	https://www.cmegroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.64%
EV Earnings	21.9x
EV Sales Forward	13.13x
EV/EBIT	21.19x
EV/EBITDA	19.7x
EV/FCF	22.17x
EV/Sales	13.82x
FCF yield	4.59%
Forward P/E	20.55x
P/B ratio	3.46x
P/E ratio	21.65x
P/S ratio	13.59x
PE Ratio10 Y	26.14x
PE Ratio3 Y	24.11x
PE Ratio5 Y	24.99x
PEG ratio	2.94x
PS Forward	12.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	65.1%
EBITDA Margin	70.01%
FCF margin	62.34%
Gross margin	100%
Gross Profit	$6.8B
Gross Profit Growth	5.04%
Gross Profit Growth Q	0.81%
Gross Profit Growth3 Y	8.93%
Gross Profit Growth5 Y	7.99%
Net Income	$4.3B
Net Income Growth	13.75%
Net Income Growth Q	1.63%
Net Income Growth Quarters	3%
Net Income Growth Years	5%
Net Income Growth3 Y	13.18%
Net Income Growth5 Y	17.3%
Pretax Margin	82.79%
Profit Margin	63.44%
Profit Per Employee	$1.1M
Profitable Quarters	$102
Profitable Years	25
ROA	1.48
Roa5y	1.38
ROCE	12.26
ROE	15.8
Roe5y	11.95
ROIC	12.16
Roic5y	9.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.98%
Cagr15y	15.29%
Cagr1y	-5.1%
Cagr20y	9.18%
Cagr3y	13.47%
Cagr5y	8.41%
Div CAGR10	8.23%
Div CAGR3	8.95%
Div CAGR5	13.4%
EPS Growth	14.17
EPS Growth Q	2.49
EPS Growth Quarters	3
EPS Growth Years	5
EPS Growth3 Y	12.97
EPS Growth5 Y	17.13
FCF Growth	2.56%
FCF Growth Q	-11.21%
FCF Growth3 Y	10.67%
FCF Growth5 Y	17.42%
OCF Growth	2.69%
OCF Growth Q	-10.52%
OCF Growth10 Y	10.47%
OCF Growth3 Y	10.52%
OCF Growth5 Y	15.75%
Revenue Growth	5.05x
Revenue Growth Q	0.81x
Revenue Growth Quarters	3x
Revenue Growth Years	4x
Revenue Growth3 Y	8.93x
Revenue Growth5 Y	7.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.04
Assets	$194.7B
Cash	$2.3B
Current Assets	$161.6B
Current Liabilities	$158.7B
Debt	$3.9B
Debt EBITDA	$0.82
Debt Equity	$0.15
Debt FCF	$0.92
Equity	$26.5B
Interest Coverage	25.21
Liabilities	$168.2B
Long Term Assets	$33B
Long Term Liabilities	$9.4B
Net Cash	$-1.6B
Net Cash By Market Cap	$-1.73
Net Debt EBITDA	$0.34
Net Debt Equity	$0.06
Net Debt FCF	$0.38
Tangible Book Value	$-3.7B
Tangible Book Value Per Share	$-10.17
WACC	5.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.02
Net Working Capital	$702.1M
Quick ratio	0.02
Working Capital	$2.9B
Working Capital Turnover	$2.43

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.31%
Dividend Growth	6.13%
Dividend Growth Years	0%
Dividend per share	$11.35
Dividend Years	24
Dividend Yield	4.45%
Ex Div Date	2026-06-09
Last Dividend	$1.3
Payout Frequency	Quarterly
Payout Ratio	95.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	270%
1Y total return	-5.1%
200-day SMA	278.6
3Y total return	46.11%
50-day SMA	255.7
50-day SMA vs 200-day SMA	50under200
5Y total return	49.71%
All Time High	329.2
All Time High Change	-22.42%
All Time High Date	2026-03-03
All Time Low	7.78
All Time Low Change	3,182.26%
All Time Low Date	2002-12-06
ATR	7.41
Beta	0.28
Beta1y	0.23
Beta2y	0.13
Ch YTD	-6.49
High	256.7
High52	329.2
High52 Date	2026-03-03
High52ch	-22.42%
Low	251.5
Low52	218.3
Low52 Date	2026-06-29
Low52ch	16.97%
Ma50ch	-0.13%
Premarket Change Percent	-0.12
Premarket Price	$255
Premarket Volume	718
Price vs 200-day SMA	-8.35%
RSI	57.92
RSI Monthly	49.63
RSI Weekly	43.94
Sharpe ratio	-0.24x
Sortino ratio	-0.09
Total Return	4.14%
Tr YTD	-3.76
Tr15y	744.57%
Tr1m	15.55%
Tr1w	4.18%
Tr3m	-9.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	16
Analyst Count Top	9
Analyst Price Target Top	$265
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$2.99
Earnings EPS Estimate Growth	1.01
Earnings Revenue Estimate	1,727,222,696x
Earnings Revenue Estimate Growth	2.08x
Operating Income	$4.4B
Operating Income Growth	5.33
Operating Income Growth Q	-1.97
Operating Income Growth3 Y	12.16
Operating Income Growth5 Y	12.39
Operating margin	65.69
Price target	$284
Price Target Change	$11.19
Price Target Change Top	$3.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	354,524,060%
Float Percent	98.59%
Net Borrowing	-1,700,000
Shares Insiders	0.28%
Shares Institutions	92.04%
Shares Out	359,579,263
Shares Qo Q	-0.52%
Shares Yo Y	0.31%
Short Float	1.65%
Short Ratio	1.47
Short Shares	1.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$4.1B
Adjusted OCF	4,209,500,000
Average Volume	3,167,794.3x
Bv Per Share	73.82
CAPEX	$-96.3M
Ch10y	151.6
Ch15y	347.8
Ch1m	15.55
Ch1w	4.18
Ch1y	-8.65
Ch20y	183.7
Ch3m	-10.42
Ch3y	28.48
Ch5y	21.35
Ch6m	-10.1
Change	0.02%
Change From Open	-0.04
Close	255.3
Days Gap	0.06
Depreciation Amortization	332,500,000
Dollar Volume	427,861,297.9
Earnings Date	2026-07-22
Earnings Time	bmo
EBIT	$4.4B
EBITDA	$4.7B
EPS	$11.79
F Score	4
FCF	$4.2B
FCF EV Yield	4.51x
FCF Per Share	$11.72
Financing CF	10,324,100,000
Fiscal Year End	December
Founded	1,898
Goodwill	10,505,800,000
Graham Number	139.95486
Graham Upside	-45.19
Income Tax	$1.3B
Investing CF	1,480,400,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-22
Last Report Date	2026-06-30
Last Split Date	2012-07-23
Last Split Type	Forward
Last10k Filing Date	2026-02-26
Lynch Fair Value	$204
Lynch Upside	-20.09
Ma150	280.8
Ma150ch	-9.07%
Ma20	241.4
Ma20ch	5.79%
Net CF	16,113,500,000
Next Earnings Date	2026-10-21
Open	255.5
Optionable	Yes
P FCF Ratio	21.8
P FCF Ratio SBC	22.32
P OCF Ratio	21.31
P OCF Ratio SBC	21.81
Payment Date	2026-06-25
Position In Range	74.9
Post Close	255.4
Postmarket Change Percent	0.06
Postmarket Price	$256
Ppne	727,200,000
Pre Close	255.3
Price Date	2026-07-27
Price EBITDA	$19.37
Relative Volume	0.53x
Revenue	6,757,200,000x
SBC By Revenue	1.47x
Share Based Comp	99,500,000
Tax By Revenue	19.34x
Tax Rate	23.36%
Tr20y	478.93%
Tr6m	-7.47%
Us State	Illinois
Views	194
Volume	1,675,522
Z Score	0.53

Frequently asked questions

About this CME report

What is the latest published CME stock rating?

CME Group Inc. is shown with reduce in the latest published report, analyzed 2026-05-20. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CME analysis?

The full latest published report, analyzed 2026-05-20, lives at /stocks/CME/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for CME?

The latest published report analyzed 2026-05-20 frames CME around USD 181 to USD 341. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the CME page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-20). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

CME Group Inc. (CME)

Coverage state: Latest published research available

Generate a fresh CME analysis

Our latest published analysis: CME rated Reduce

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CME

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All CME indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CME

Frequently asked questions